Polychlorinated biphenyls (PCBs) are persistent organic pollutants that have promoting activity in the liver. PCBs induce oxidative stress, which may influence carcinogenesis. Epidemiological studies strongly suggest an inverse relationship between dietary selenium (Se) and cancer. Despite evidence linking Se deficiency to hepatocellular carcinoma and liver necrosis, the underlying mechanisms for Se cancer protection in the liver remain to be determined. We examined the effect of dietary Se on the tumor promoting activities of two PCBs congeners, 3,3′, 4,4′-tetrachlorobiphenyl (PCB-77) and 2,2′, 4,4′, 5,5′-hexachlorobiphenyl (PCB-153) using a 2-stage carcinogenesis model. An AIN-93 torula yeast-based purified diet containing 0.02 (deficient), 0.2 (adequate), or 2.0 mg (supplemental) selenium/kg diet was fed to Sprague-Dawley female rats starting ten days after administering a single dose of diethylnitrosamine (150 mg/kg). After being fed the selenium diets for 3 weeks, rats received four i.p. injections of either PCB-77 or PCB-153 (150 μ mol/kg) administered every 14 days. The number of placental glutathione S-transferase (PGST)-positive foci per cm3 and per liver among the PCB-77–treated rats was increased as the Se dietary level increased. Unlike PCB-77, rats receiving PCB-153 did not show the same Se dose-response effect; nevertheless, Se supplementation did not confer protection against foci development. However, the 2.0 ppm Se diet reduced the mean focal volume, indicating a possible protective effect by inhibiting progression of preneoplastic lesions into larger foci. Cell proliferation was not inhibited by Se in the liver of the PCB-treated groups. Se did not prevent the PCB-77–induced decrease of hepatic Se and associated reduction in glutathione peroxidase (GPx) activity. In contrast, thioredoxin reductase (TrxR) activity was not affected by the PCBs treatment or by Se supplementation. These findings indicate that Se does not inhibit the number of PGST-positive foci induced during promotion by PCBs, but that the size of the lesions may be inhibited. The effects of Se on altered hepatic foci do not correlate with its effects on GPx and TrxR.
Get full access to this article
View all access options for this article.
References
1.
Schrauzer GN. Selenium and cancer: a review. Bioinorg Chem5:275–281, 1976.
2.
Clark LC, Combs GF, Jr., Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL, Jr., Park HK, Sanders BB, Jr., Smith CL, Taylor JR. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA276:1957–1963, 1996.
3.
Combs GF, Jr. Chemopreventive mechanisms of selenium. Med Klin94 (Suppl 3):18–24, 1999.
4.
Ganther HE. Selenium metabolism and mechanisms of cancer prevention. Adv Exp Med Biol492:119–130, 2001.
Ip C. Lessons from basic research in selenium and cancer prevention. J Nutr128:1845–1854, 1998.
7.
Iwata H, Tanabe S, Sakai N, Nishimura A, Tatsukawa R. Geographical distribution of persistent organochlorines in air, water and sediments from Asia and Oceania, and their implications for global redistribution from lower latitudes. Environ Pollut85:15–33, 1994.
8.
Chiba I, Sakakibara A, Iwata TH, Ishizuka M, Tanabe S, Akahori F, Kazusaka A, Fujita S. Hepatic microsomal cytochrome p450s and chlorinated hydrocarbons in largha and ribbon seals from Hokkaido, Japan: differential response of seal species to Ah receptor agonist exposure. Environ Toxicol Chem21:794–806, 2002.
9.
Hildebrand H, Schmidt U, Kempka G, Jacob R, Ahr HJ, Ebener C, Goretzki PE, Bader A. An in vitro model for peroxisome proliferation utilizing primary hepatocytes in sandwich culture. Toxicol Vitro13: 265–273, 1999.
10.
Safe SH. Polychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic responses, and implications for risk assessment. Crit Rev Toxicol24:87–149, 1994.
11.
Kafafi SA, Afeefy HY, Ali AH, Said HK, Abd-Elazem IS, Kafafi AG. Affinities for the aryl hydrocarbon receptor, potencies as aryl hydrocarbon hydroxylase inducers and relative toxicities of polychlorinated biphenyls. A congener specific approach. Carcinogenesis14:2063–2071, 1993.
12.
Zelko I, Negishi M. Phenobarbital-elicited activation of nuclear receptor CAR in induction of cytochrome P450 genes. Biochemical and Biophysical Research Communications277:1–6, 2000.
13.
Sakai H, Iwata H, Kim EY, Tsydenova O, Miyazaki N, Petrov EA, Batoev VB, Tanabe S. Constitutive androstane receptor (CAR) as a potential sensing biomarker of persistent organic pollutants (POPs) in aquatic mammal: molecular characterization, expression level, and ligand profiling in Baikal seal (Pusa sibirica). Toxicol Sci94:57–70, 2006.
14.
Robertson LW, Hansen LG. PCBs: Recent Advances in Environmental Toxicology and Health Effects. Lexington, KY: University Press of Kentucky, 2001.
15.
Sinks T, Steele G, Smith AB, Watkins K, Shults RA. Mortality among workers exposed to polychlorinated biphenyls. Am J Epidemiol136: 389–398, 1992.
16.
Loomis D, Browning SR, Schenck AP, Gregory E, Savitz DA. Cancer mortality among electric utility workers exposed to polychlorinated biphenyls. Occup Environ Med54:720–728, 1997.
17.
Kimbrough RD, Krouskas CA. Human exposure to polychlorinated biphenyls and health effects: a critical synopsis. Toxicol Rev22:217–233, 2003.
18.
Lawton RW, Ross MR, Feingold J, Brown JF, Jr. Effects of PCB exposure on biochemical and hematological findings in capacitor workers. Environ Health Perspect60:165–184, 1985.
19.
Silberhorn EM, Glauert HP, Robertson LW. Carcinogenicity of polyhalogenated biphenyls: PCBs and PBBs. Crit Rev Toxicol20: 440–496, 1990.
20.
Mayes BA, McConnell EE, Neal BH, Brunner MJ, Hamilton SB, Sullivan TM, Peters AC, Ryan MJ, Toft JD, Singer AW, Brown JF, Menton RG, Moore JA. Comparative carcinogenicity in Sprague-Dawley rats of the polychlorinated biphenyl mixtures Aroclors 1016, 1242, 1254, and 1260. Fundam Appl Toxicol41:62–76, 1998.
21.
Glauert HP, Robertson LW, Silberhorn EM. PCBs and tumor promotion. In: Robertson LW, Hansen LG, Eds. PCBs: Recent Advances in Environmental Toxicology and Health Effects. Lexington, KY: University Press of Kentucky, pp355–371, 2001.
22.
Espandiari P, Glauert HP, Lehmler HJ, Lee EY, Srinivasan C, Robertson LW. Polychlorinated biphenyls as initiators in liver carcinogenesis: resistant hepatocyte model. Toxicol Appl Pharmacol186:55–62, 2003.
23.
Schramm H, Robertson LW, Oesch F. Differential regulation of hepatic glutathione transferase and glutathione peroxidase activities in the rat. Biochem Pharmacol34:3735–3739, 1985.
24.
Reeves PG, Nielsen FH, Fahey GC. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A diet. J Nutr123:1939–1951, 1993.
25.
Tharappel JC, Lee EY, Robertson LW, Spear BT, Glauert HP. Regulation of cell proliferation, apoptosis, and transcription factor activities during the promotion of liver carcinogenesis by polychlorinated biphenyls. Toxicol Appl Pharmacol179:172–184, 2002.
26.
Murdoch A, Jenkinson EJ, Johnson GD, Owen JJ. Alkaline phosphatase-fast red, a new fluorescent label. J Immunol Methods132:45–49, 1990.
27.
Campbell HA, Pitot HC, Porter VR, Laishes BA. Application of quantitative stereology to the evaluation of enzyme-altered foci in rat liver. Cancer Res42:465–472, 1982.
28.
Campbell HA, Xu YD, Hanigan MH, Pitot HC. Application of quantitative stereology to the evaluation of phenotypically heterogeneous enzyme-altered foci in the rat liver. J Natl Cancer Inst76:751–767, 1986.
29.
Xu YH, Dragan YP, Campbell HA, Pitot HC. STEREO: a program on a PC-Windows 95 platform for recording and evaluating quantitative stereologic investigations of multistage hepatocarcinogenesis in rodents. Comput Methods Programs Biomed56:49–63, 1998.
30.
Xu YH, Pitot HC. Building quantitative stereology data files with scion image, a public domain image processing and analysis software. Comput Methods Programs Biomed59:131–142, 1999.
31.
Hill KE, McCollum GW, Burk RF. Determination of thioredoxin reductase activity in rat liver supernatant. Anal Biochem253:123–125, 1997.
32.
Hill KE, McCollum GW, Boeglin ME, Burk RF. Thioredoxin reductase activity is decreased by selenium deficiency. Biochem Biophys Res Commun234:293–295, 1997.
33.
Holmgren A, Bjornstedt M. Thioredoxin and thioredoxin reductase. Methods Enzymol252:199–208, 1995.
34.
Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med70:158–169, 1967.
35.
St. Clair D, Chow C. Glutathione peroxidase: activity and steady state level of mRNA. In: Punchard E, Kelley F, Eds. Free Radicals: A Practical Approach. Oxford: Oxford University Press, pp327–340, 1996.
36.
Chow CK, Gairola CC. Influence of dietary selenium on the hepatic and pulmonary enzymes in polychlorobiphenyls-treated rats. Cancer Detect Prev4:135–139, 1981.
37.
Twaroski TP, O’Brien ML, Robertson LW. Effects of selected polychlorinated biphenyl (PCB) congeners on hepatic glutathione, glutathione-related enzymes, and selenium status: implications for oxidative stress. Biochem Pharmacol62:273–281, 2001.
38.
Ip C, Dong Y, Ganther HE. New concepts in selenium chemo-prevention. Cancer Metastasis Rev21:281–289, 2002.
39.
Berberian I, Chen LC, Robinson FR, Glauert HP, Chow CK, Robertson LW. Effect of dietary retinyl palmitate on the promotion of altered hepatic foci by 3,3′, 4,4′-tetrachlorobiphenyl and 2,2′, 4,4′, 5,5′-hexa-chlorobiphenyl in rats initiated with diethylnitrosamine. Carcinogenesis16:393–398, 1995.
40.
Tharappel JC, Lee EY, Robertson LW, Spear BT, Glauert HP. Regulation of cell proliferation, apoptosis, and transcription factor activities during the promotion of liver carcinogenesis by polychlorinated biphenyls. Toxicol Appl Pharmacol179:172–184, 2002.
41.
Kobusch A-B, Fischer G, Bock KW. Tumor-promoting activity and cytotoxicity of 3,4,3′, 4′-tetrachlorobiphenyl on N-nitrosomorpholine-induced murine liver foci. J Cancer Res Clin Oncol115:247–252, 1989.
42.
Sargent L, Dragan YP, Erickson C, Laufer CJ, Pitot HC. Study of the separate and combined effects of the non-planar 2,5,2′, 5′- and the planar 3,4,3′, 4′-tetrachlorobiphenyl in liver and lymphocytes in vivo. Carcinogenesis12:793–800, 1991.
43.
Wölfle D, Munzel P, Fischer G, Bock KW. Altered growth control of rat hepatocytes after treatment with 3,4,3′, 4′-tetrachlorobiphenyl in vivo and in vitro. Carcinogenesis9:919, 1988.
44.
Buchmann A, Ziegler S, Wolf A, Robertson LW, Durham SK, Schwarz M. Effects of polychlorinated biphenyls in rat liver: correlation between primary subcellular effects and promoting activity. Toxicol Appl Pharmacol111:454–468, 1991.
45.
Buchmann A, Kunz W, Wolf CR, Oesch F, Robertson LW. Polychlorinated biphenyls, classified as either phenobarbital- or 3-methlycholanthrene-type inducers of cytochrome P-450, are both hepatic tumor promoters in diethylnitrosoamine-initiated rats. Cancer Let32:243–253, 1986.
46.
Hemming H, Flodstrom S, Warngard L, Bergman A, Kronevi T, Nordgren I, Ahlborg UG. Relative tumour promoting activity of three polychlorinated biphenyls in rat liver. Eur J Pharmacol-Environ Toxic248:163–174, 1993.
47.
Laib RJ, Rose N, Brunn H. Hepatocarcinogenicity of PCB congeners. I. Initiation and promotion of enzyme-altered rat liver foci by 2,2′, 4,5′-tetra- and 2,2′, 4,4′, 5,5′-hexachlorobiphenyl. Toxicol Environ Chem34:19–22, 1991.
48.
Dean CE, Benjamin SA, Chubb LS, Tessari JD, Keefe TJ. Nonadditive hepatic tumor promoting effects by a mixture of two structurally different polychlorinated biphenyls in female rat livers. Toxicol Sci66: 54–61, 2002.
49.
Dorado RD, Porta EA, Aquino TM. Effects of dietary selenium on hepatic and renal tumorigenesis induced in rats by diethylnitrosamine. Hepatology5:1201–1208, 1985.
50.
Aquino TM, Porta EA, Sablan HM, Dorado RD. Effects of selenium supplementation on hepatocarcinogenesis in rats. Nutr Cancer7:25–36, 1985.
51.
Milks MM, Wilt SR, Ali, II, Couri D. The effects of selenium on the emergence of aflatoxin B1-induced enzyme- altered foci in rat liver. Fundam Appl Toxicol5:320–326, 1985.
52.
Baldwin S, Parker RS. Influence of dietary fat and selenium in initiation and promotion of aflatoxin B1-induced preneoplastic foci in rat liver. Carcinogenesis8:101–107, 1987.
53.
Bjorkhem-Bergman L, Torndal UB, Eken S, Nystrom C, Capitanio A, Larsen EH, Bjornstedt M, Eriksson LC. Selenium prevents tumor development in a rat model for chemical carcinogenesis. Carcinogenesis26:125–131, 2005.
54.
LeBoeuf RA, Laishes BA, Hoekstra WG. Effects of dietary selenium concentration on the development of enzyme- altered liver foci and hepatocellular carcinoma induced by diethylnitrosamine or N-acetylaminofluorene in rats. Cancer Res45:5489–5495, 1985.
55.
Lei DN, Wang LQ, Ruebner BH, Hsieh DP, Wu BF, Zhu CR, Du MJ. Effect of selenium on aflatoxin hepatocarcinogenesis in the rat. Biomed Environ Sci3:65–80, 1990.
56.
Glauert HP, Beaty MM, Clark TD, Greenwell WS, Chow CK. Effect of dietary selenium on the induction of altered hepatic foci and hepatic tumors by the peroxisome proliferator ciprofibrate. Nutr Cancer14: 261–271, 1990.
57.
Wilson AC, Thompson HJ, Schedin PJ, Gibson NW, Ganther HE. Effect of methylated forms of selenium on cell viability and the induction of DNA strand breakage. Biochem Pharmacol43:1137–1141, 1992.
58.
Thompson NL, Lin SH, Panzica MA, Hixson DC. Cell CAM 105 isoform RNA expression is differentially regulated during rat liver regeneration and carcinogenesis. Pathobiology62:209–220, 1994.
59.
Stadtman TC. Selenocysteine. Annu Rev Biochem65:83–100, 1996.
60.
Ganther HE. Reduction of the selenotrisulfide derivative of glutathione to a persulfide analog by glutathione reductase. Biochemistry10:4089–4098, 1971.
61.
McKenzie RC, Arthur JR, Beckett GJ. Selenium and the regulation of cell signaling, growth, and survival: molecular and mechanistic aspects. Antioxid Redox Signal4:339–351, 2002.
62.
Stewart MS, Spallholz JE, Neldner KH, Pence BC. Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radic Biol Med26:42–48, 1999.
63.
Sinha R, Unni E, Ganther HE, Medina D. Methylseleninic acid, a potent growth inhibitor of synchronized mouse mammary epithelial tumor cells in vitro. Biochem Pharmacol61:311–317, 2001.
64.
Weiller M, Latta M, Kresse M, Lucas R, Wendel A. Toxicity of nutritionally available selenium compounds in primary and transformed hepatocytes. Toxicology201:21–30, 2004.
65.
Spallholz JE. On the nature of selenium toxicity and carcinostatic activity. Free Radic Biol Med17:45–64, 1994.
66.
Farber E, Solt D, Cameron R, Laishes B, Ogawa K. Newer insights into the pathogenesis of liver cancer. Am J Pathol89:477–482, 1977.
67.
Ip C, White G. Mammary cancer chemoprevention by inorganic and organic selenium: single agent treatment or in combination with vitamin E and their effects on in vitro immune functions. Carcinogenesis8:1763–1766, 1987.
68.
Thompson HJ, Meeker LD, Kokoska S. Effect of an inorganic and organic form of dietary selenium on the promotional stage of mammary carcinogenesis in the rat. Cancer Res44:2803–2806, 1984.
69.
Elbayoumy K. The protective role of selenium on genetic damage and on cancer. Mutat Res Fundam Mol Mech Mut475:123–139, 2001.
70.
Gromer S, Urig S, Becker K. The thioredoxin system–from science to clinic. Med Res Rev24:40–89, 2004.
71.
Kohrl J, Brigelius-Flohe R, Bock A, Gartner R, Meyer O, Flohe L. Selenium in biology: facts and medical perspectives. Biol Chem381: 849–864, 2000.
72.
Lei XG. Glutathione peroxidase-1 gene knockout on body antioxidant defense in mice. Biofactors14:93–99, 2001.
73.
Sunde RA, Thompson BM, Palm MD, Weiss SL, Thompson KM, Evenson JK. Selenium regulation of selenium-dependent glutathione peroxidases in animals and transfected CHO cells. Biomed Environ Sci10:346–355, 1997.
74.
Ho YS, Magnenat JL, Bronson RT, Cao J, Gargano M, Sugawara M, Funk CD. Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J Biol Chem272:16644–16651, 1997.
75.
Ip C. Factors influencing the anticarcinogenic efficacy of selenium in dimethylbenz[a]anthracene-induced mammary tumorigenesis in rats. Cancer Res41:2683–2686, 1981.
76.
Burk RF, Hill KE. Regulation of selenoproteins. Annu Rev Nutr13:65–81, 1993.
77.
Lane HW, Medina D. Selenium concentration and glutathione peroxidase activity in normal and neoplastic development of the mouse mammary gland. Cancer Res43:1558–1561, 1983.
78.
Ganther HE. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis20:1657–1666, 1999.
79.
Lu YP, Lou YR, Yen P, Newmark HL, Mirochnitchenko OI, Inouye M, Huang MT. Enhanced skin carcinogenesis in transgenic mice with high expression of glutathione peroxidase or both glutathione peroxidase and superoxide dismutase. Cancer Res57:1468–1474, 1997.
80.
Powis G, Gasdaska JR, Gasdaska PY, Berggren M, Kirkpatrick DL, Engman L, Cotgreave IA, Angulo M, Baker A. Selenium and the thioredoxin redox system: effects on cell growth and death. Oncol Res9:303–312, 1997.
81.
Berggren MI, Husbeck B, Samulitis B, Baker AF, Gallegos A, Powis G. Thioredoxin peroxidase-1 (peroxiredoxin-1) is increased in thioredoxin-1 transfected cells and results in enhanced protection against apoptosis caused by hydrogen peroxide but not by other agents including dexamethasone, etoposide, and doxorubicin. Arch Biochem Biophys392:103–109, 2001.
82.
Anestal K, Arner ES. Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine. J Biol Chem278:15966–15972, 2003.
83.
Berggren MM, Mangin JF, Gasdaka JR, Powis G. Effect of selenium on rat thioredoxin reductase activity: increase by supranutritional selenium and decrease by selenium deficiency. Biochem Pharmacol57: 187–193, 1999.
84.
Gallegos A, Berggren M, Gasdaska JR, Powis G. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium. Cancer Res57:4965–4970, 1997.
85.
Gladyshev VN, Factor VM, Housseau F, Hatfield DL. Contrasting patterns of regulation of the antioxidant selenoproteins, thioredoxin reductase, and glutathione peroxidase, in cancer cells. Biochem Biophys Res Commun251:488–493, 1998.
86.
Ganther H, Ip C. Thioredoxin reductase activity in rat liver is not affected by supranutritional levels of monomethylated selenium in vivo and is inhibited only by high levels of selenium in vitro. J Nutr131: 301–304, 2001.
87.
Stemm DN, Robertson LW, Tharappel JC, Glauert HP. Effects of 3,3′, 4,4′-tetrachlorobiphenyl (PCB 77) on the distribution and metabolism of selenium in rats. Toxicol Sci78 (1-S):206, 2004.
